Zepbound beats Wegovy for weight loss
Digest more
The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference. And one clearly comes out on top.
The Associated Press on MSN12d
Lilly star weight-loss drug Zepbound faces coverage challenge from CVS HealthEli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the ... Coach John Harbaugh provides insight.